Step 8: Label the vial with the reconstitution date, the concentration (5mg/ml or 10mg/ml), and the amount of tirzepatide
Maintenance shifts the focus to weight stability, hunger, strength, and laboratory results
One phase two trial (mean age 58, with no upper age limit) demonstrated mean reduction in body weight of 15.6% in participants taking CagriSema, compared to 5.1% and 8.1% with semaglutide and cagrilintide in monotherapy, respectively, over 32 weeks
Reported research has examined its role in cellular-repair pathways, including angiogenic activity and modulation of growth-factor signalling, across tendon, ligament, muscle, and intestinal-tissue research models, as well as its interaction with nitric-oxide pathways and gut-barrier function